Tamiflu “Wrap-up” and Five Questions for the Committee Linda L. Lewis, M.D. Division of Antiviral Products CDER, FDA - Acetamides - Document - PDFSEARCH.IO

First Page	Meta Content
	Tamiflu “Wrap-up” and Five Questions for the Committee Linda L. Lewis, M.D. Division of Antiviral Products CDER, FDA Add to Reading List Document Date: 2007-12-12 08:45:12 Open Document File Size: 32,17 KB Share Result on Facebook Country Japan / United States / / IndustryTerm influenza products / antiviral products / / MedicalCondition influenza / influenza encephalopathy/encephalitis / disease / / Organization FDA / Division of Antiviral Products CDER / / Person Linda L. Lewis / / Product Tamiflu / / SocialTag Neuraminidase inhibitors Amines GlaxoSmithKline Guanidines Zanamivir Oseltamivir Amantadine Rimantadine Influenza Chemistry

Tamiflu “Wrap-up” and Five Questions for the Committee Linda L. Lewis, M.D. Division of Antiviral Products CDER, FDAAdd to Reading List